Advertisement
Screener

Evome Medical Technologies, Inc. Increase (Decrease) in Accounts Receivable

Evome Medical Technologies, Inc. Increase (Decrease) in Accounts Receivable

Evome Medical Technologies, Inc. reported Increase (Decrease) in Accounts Receivable of CAD 1.90 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2024-04-16

  • Evome Medical Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-12-31 was -1.49M CAD.
  • Evome Medical Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-09-30 was -993.95K CAD, a 142.95% decline year-over-year.
  • Evome Medical Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-06-30 was 3.23M CAD.
  • Evome Medical Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-03-31 was 1.16M CAD, a 15.36% increase year-over-year.
  • Evome Medical Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2023 was 1.90M CAD.
  • Evome Medical Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2022 was 2.07M CAD.
  • Evome Medical Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2021 was 0.00 CAD.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 10 monthIncrease (Decrease) in Accounts Receivable 12 month
2023-12-31-1.49M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
-2.49M CAD
derived: sum of 2 quarters · filed 2024-04-16
741.83K CAD
derived: sum of 3 quarters · filed 2024-04-16
1.90M CAD
10-K · filed 2024-04-16
2023-09-30-993.95K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
2.23M CAD
derived: sum of 2 quarters · filed 2023-11-14
3.39M CAD
10-Q · filed 2023-11-14
2023-06-303.23M CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
4.39M CAD
10-Q · filed 2023-08-14
2023-03-311.16M CAD
10-Q · filed 2023-05-15
2022-12-31-1.66M CAD
10-K · filed 2024-04-16
2022-11-30-1.23M CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17
-491.44K CAD
10-Q · filed 2023-01-17
2022-09-302.31M CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
1.82M CAD
10-Q · filed 2023-11-14
2022-08-31627.68K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17
738.34K CAD
10-Q · filed 2022-10-17
2022-06-30-1.50M CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-492.48K CAD
10-Q · filed 2023-08-14
2022-05-31110.66K CAD
10-Q · filed 2022-07-15
2022-03-311.01M CAD
10-Q · filed 2023-05-15
2022-02-281.00M CAD
derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03
1.27M CAD
derived: sum of 2 quarters · filed 2023-04-03
1.87M CAD
derived: sum of 3 quarters · filed 2023-04-03
2.07M CAD
10-KT · filed 2023-04-03
2021-12-311.58M CAD
10-KT · filed 2023-04-03
2021-11-30273.83K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17
872.11K CAD
derived: sum of 2 quarters · filed 2023-01-17
1.07M CAD
10-Q · filed 2023-01-17
1.07M CAD
derived: sum of 4 quarters · filed 2023-01-17
2021-08-31598.28K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17
791.84K CAD
10-Q · filed 2022-10-17
791.84K CAD
derived: sum of 3 quarters · filed 2022-10-17
791.84K CAD
derived: sum of 4 quarters · filed 2022-10-17
2021-05-31193.56K CAD
10-Q · filed 2022-07-15
193.56K CAD
derived: sum of 2 quarters · filed 2022-07-15
193.56K CAD
derived: sum of 3 quarters · filed 2022-07-15
2021-02-280.00 CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
0.00 CAD
derived: sum of 2 quarters · filed 2022-05-31
0.00 CAD
10-K · filed 2022-05-31
2020-11-300.00 CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-14
0.00 CAD
10-Q · filed 2022-01-14
2020-08-310.00 CAD
10-Q · filed 2021-10-15